摘要
糖尿病 (DM) 是一种慢性疾病,对世界健康构成威胁。对抗疗法药物在控制 DM 及其并发症方面不够有效。因此,传统医学体系受到了很多关注。具有药用特性的植物衍生天然化合物在 DM 管理和治疗中发挥着重要作用。艾蒿是菊科的一个种类繁多且分布广泛的属,有 500 多个物种,具有有益的经济和治疗意义。 Science Direct、Scopus、Pubmed、Web of Science、medRixv 和 Wiley 等电子数据库用于搜索科学文献。在民间传说医学中,蒿属植物已被广泛用于糖尿病管理。分子研究表明,NF-κB 抑制、Notch 1 抑制、细胞周期在 S+G2/M 期停止、Bax 蛋白浓度增加、线粒体膜电位衰减、p53 和 caspase 的激活、Bcl-2 调节和 ROS形成是可以通过各种蒿属植物靶向的关键机制。单剂量或多剂量的蒿属植物酒精和水提取物的抗糖尿病作用是由于存在生物活性化合物,它们在实验检查中完全有效地降低血糖水平。尽管有可用的抗糖尿病药物,但从上述植物中获得的治疗剂已被用于治疗这种疾病及其并发症,而且副作用较小。综合起来,多条证据表明,蒿属植物可以作为潜在的治疗候选者用于糖尿病的治疗和管理。
关键词: 糖尿病,艾蒿,草药,分子途径,抗糖尿病潜力,菊科。
Current Molecular Medicine
Title:Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review
Volume: 21 Issue: 10
关键词: 糖尿病,艾蒿,草药,分子途径,抗糖尿病潜力,菊科。
摘要: Diabetes mellitus (DM) is a chronic disease and a threatening problem for world health. Allopathic medications are not efficient enough in controlling DM and its complications. Therefore, much attention has been directed towards the traditional medicine system. Plant derived-natural compounds with medicinal properties play an essential role in DM management and treatment. Artemisia is a varied and widespread genus of the family Asteraceae, which has more than 500 species with beneficial economic and therapeutic significance. Electronic databases such as Science Direct, Scopus, Pubmed, Web of Science, medRixv, and Wiley were used to search scientific literature. In folklore medicine, Artemisia species have been widely utilized for diabetes management. Molecular investigations have revealed that the NF-κB suppression, Notch 1 inhibition, cell cycle stop at S+G2/M-phase, enhanced Bax protein concentrations, mitochondrial membrane potential attenuation, activation of p53 and caspase, Bcl-2 regulation, and ROS formation are crucial mechanisms that could be targeted via various Artemisia species. Anti-diabetic effects of single or multiple doses of alcoholic and aqueous extracts of Artemisia species are due to the presence of bioactive compounds, and they are completely efficient in lowering levels of blood glucose in experimental examinations. In spite of the available anti-diabetic drugs, therapeutic agents obtained from the mentioned plants have been used for the treatment of this disease and its complications with less adverse impacts. Taken together, multiple lines of evidence indicated that Artemisia species could be introduced as a potential therapeutic candidate in the treatment and management of diabetes.
Export Options
About this article
Cite this article as:
Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review, Current Molecular Medicine 2021; 21 (10) . https://dx.doi.org/10.2174/1566524020999210101234317
DOI https://dx.doi.org/10.2174/1566524020999210101234317 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Women and Schizophrenia: Sex-Based Pharmacotherapy
Current Psychiatry Reviews Common and Less Common Peripheral Nerve Disorders Associated with Diabetes
Current Diabetes Reviews AMPA Glutamate Receptors and Neuropathic Pain
Mini-Reviews in Medicinal Chemistry Cytokine and Nitric Oxide Production Following Severe Envenomation
Current Drug Targets - Inflammation & Allergy Antimicrobial Resistance in the 21st Century: A Multifaceted Challenge
Protein & Peptide Letters Lipid Nanocarriers (LNC) and their Applications in Ocular Drug Delivery
Current Medicinal Chemistry Possible Therapies of Septic Shock: Based on Animal Studies and Clinical Trials
Current Pharmaceutical Design Synthesis and Bioactivity of (R)-Ricinoleic Acid Derivatives: A Review
Current Medicinal Chemistry Necrotizing Enterocolitis: Clinical Features, Histopathological Characteristics, and Genetic Associations
Current Pediatric Reviews GHB Pharmacology and Toxicology: Acute Intoxication, Concentrations in Blood and Urine in Forensic Cases and Treatment of the Withdrawal Syndrome
Current Neuropharmacology Autonomic Neural Functions in Space
Current Pharmaceutical Biotechnology Neuroprotection and Sex Steroid Hormones: Evidence of Estradiol- Mediated Protection in Hypertensive Encephalopathy
Mini-Reviews in Medicinal Chemistry Vaccine Development for Group A Streptococcus Infections and Associated Diseases
Current Drug Targets Oxytocin in the Heart Regeneration
Recent Patents on Cardiovascular Drug Discovery Gene Therapy and Biologic Therapy with Interleukin?4
Current Gene Therapy Recent Advances in the MCRs Synthesis of Chromenes: A Review
Current Organic Chemistry The Role of Niacin in Lipid-lowering Treatment: Are we Aiming Too High?
Current Pharmaceutical Design Bisthiourea Derivatives of Dipeptide Conjugated Benzo[d]isoxazole as a New Class of Therapeutics: Synthesis and Molecular Docking Studies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Current Status of Computer-Aided Drug Design for Type 2 Diabetes
Current Computer-Aided Drug Design Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy